vs

Side-by-side financial comparison of Guardian Pharmacy Services, Inc. (GRDN) and Oportun Financial Corp (OPRT). Click either name above to swap in a different company.

Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($397.6M vs $247.7M, roughly 1.6× Oportun Financial Corp). Guardian Pharmacy Services, Inc. runs the higher net margin — 5.3% vs 1.4%, a 3.9% gap on every dollar of revenue.

CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.

Oportun Financial Corp is a US-based fintech firm that provides accessible, responsible financial services including personal loans, credit cards, and savings products to underserved low-to-moderate income consumers, many with limited or no credit history, leveraging proprietary AI underwriting to deliver fair terms while mitigating operational risk.

GRDN vs OPRT — Head-to-Head

Bigger by revenue
GRDN
GRDN
1.6× larger
GRDN
$397.6M
$247.7M
OPRT
Higher net margin
GRDN
GRDN
3.9% more per $
GRDN
5.3%
1.4%
OPRT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GRDN
GRDN
OPRT
OPRT
Revenue
$397.6M
$247.7M
Net Profit
$20.9M
$3.4M
Gross Margin
21.5%
Operating Margin
7.7%
2.6%
Net Margin
5.3%
1.4%
Revenue YoY
-1.3%
Net Profit YoY
-61.0%
EPS (diluted)
$0.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GRDN
GRDN
OPRT
OPRT
Q4 25
$397.6M
$247.7M
Q3 25
$377.4M
$238.7M
Q2 25
$344.3M
$234.3M
Q1 25
$329.3M
$235.9M
Q4 24
$250.9M
Q3 24
$314.4M
$250.0M
Q2 24
$250.4M
Q1 24
$250.5M
Net Profit
GRDN
GRDN
OPRT
OPRT
Q4 25
$20.9M
$3.4M
Q3 25
$9.8M
$5.2M
Q2 25
$9.0M
$6.9M
Q1 25
$9.4M
$9.8M
Q4 24
$8.7M
Q3 24
$-122.0M
$-30.0M
Q2 24
$-31.0M
Q1 24
$-26.4M
Gross Margin
GRDN
GRDN
OPRT
OPRT
Q4 25
21.5%
Q3 25
19.8%
Q2 25
19.8%
Q1 25
19.5%
Q4 24
Q3 24
19.4%
Q2 24
Q1 24
Operating Margin
GRDN
GRDN
OPRT
OPRT
Q4 25
7.7%
2.6%
Q3 25
4.3%
6.0%
Q2 25
3.7%
4.3%
Q1 25
3.9%
5.6%
Q4 24
89.6%
Q3 24
-33.3%
-15.8%
Q2 24
-19.6%
Q1 24
-12.2%
Net Margin
GRDN
GRDN
OPRT
OPRT
Q4 25
5.3%
1.4%
Q3 25
2.6%
2.2%
Q2 25
2.6%
2.9%
Q1 25
2.9%
4.1%
Q4 24
200.1%
Q3 24
-38.8%
-12.0%
Q2 24
-12.4%
Q1 24
-10.6%
EPS (diluted)
GRDN
GRDN
OPRT
OPRT
Q4 25
$0.07
Q3 25
$0.11
Q2 25
$0.14
Q1 25
$0.21
Q4 24
$0.26
Q3 24
$-0.75
Q2 24
$-0.78
Q1 24
$-0.68

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GRDN
GRDN
OPRT
OPRT
Cash + ST InvestmentsLiquidity on hand
$65.6M
$105.5M
Total DebtLower is stronger
$0
Stockholders' EquityBook value
$217.9M
$390.1M
Total Assets
$412.7M
$3.3B
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GRDN
GRDN
OPRT
OPRT
Q4 25
$65.6M
$105.5M
Q3 25
$36.5M
$104.6M
Q2 25
$18.8M
$96.8M
Q1 25
$14.0M
$78.5M
Q4 24
$60.0M
Q3 24
$37.2M
$71.8M
Q2 24
$72.9M
Q1 24
$69.2M
Total Debt
GRDN
GRDN
OPRT
OPRT
Q4 25
$0
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$34.3M
Q2 24
Q1 24
Stockholders' Equity
GRDN
GRDN
OPRT
OPRT
Q4 25
$217.9M
$390.1M
Q3 25
$195.5M
$383.9M
Q2 25
$179.7M
$376.0M
Q1 25
$163.2M
$366.1M
Q4 24
$353.8M
Q3 24
$133.9M
$327.6M
Q2 24
$354.1M
Q1 24
$382.0M
Total Assets
GRDN
GRDN
OPRT
OPRT
Q4 25
$412.7M
$3.3B
Q3 25
$390.0M
$3.2B
Q2 25
$356.3M
$3.2B
Q1 25
$334.0M
$3.2B
Q4 24
$3.2B
Q3 24
$348.0M
$3.3B
Q2 24
$3.3B
Q1 24
$3.3B
Debt / Equity
GRDN
GRDN
OPRT
OPRT
Q4 25
0.00×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.26×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GRDN
GRDN
OPRT
OPRT
Operating Cash FlowLast quarter
$34.6M
$413.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.65×
121.45×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GRDN
GRDN
OPRT
OPRT
Q4 25
$34.6M
$413.4M
Q3 25
$28.2M
$99.0M
Q2 25
$19.9M
$104.5M
Q1 25
$17.6M
$101.0M
Q4 24
$393.5M
Q3 24
$108.5M
Q2 24
$107.7M
Q1 24
$85.9M
Free Cash Flow
GRDN
GRDN
OPRT
OPRT
Q4 25
Q3 25
$24.2M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
GRDN
GRDN
OPRT
OPRT
Q4 25
Q3 25
6.4%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
GRDN
GRDN
OPRT
OPRT
Q4 25
Q3 25
1.1%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Cash Conversion
GRDN
GRDN
OPRT
OPRT
Q4 25
1.65×
121.45×
Q3 25
2.87×
19.05×
Q2 25
2.21×
15.20×
Q1 25
1.86×
10.34×
Q4 24
45.04×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons